129 / 160
129
REFERENCIAS BIBLIOGRÁFICAS
1. Mercuri E, Bertini E, Iannaccone ST. Childhood spinal
muscular atrophy: controversies and challenges. Lancet Neurol
2012;11(5):443–52.
2. Castiglioni C, Rodillo E, Hervias C. Avances en el diagnóstico
y manejo de las enfermedades neuromusculares. REV. MED.
CLIN. CONDES - 2008; 19(5) 536 – 545.
3. Castiglioni C, Levican J, Rodillo E, Garmendia M, Diaz A, Pizarro
L, et al. Atrofia muscular espinal: Caracterización clínica,
electrofisiológica y molecular de 26 pacientes. Rev Med Chile
2011; 139: 197-204.
4. Bladen C, et col. Mapping the differences in care for 5,000
spinal muscular atrophy patients, a survey of 24 national
registries in North America, Australasia and Europe. J Neurol.
2014 Jan;261(1):152-63.
5. Wang CH1, Finkel RS, Bertini ES, et al. Standard of Care.
Consensus statement for standard of care in spinal muscular
atrophy. J Child Neurol. 2007 Aug 22(8) 1027-49.
6. Sansone, Racca F, Ottonello G, et al. on behalf of the Italian
SMA Family Association, 1st Italian SMA Family Association
Consensus Meeting:, Neuromuscular Disorders 2015; 979-989
7. Oskoui M, Levy G, Garland CJ, et al. The changing natural
history of spinal muscular atrophy type 1. Neurology.
2007;69(20):1931-6.
8. Faravelli I, Nizzardo M, ComiGP, Corti S. Spinal muscla atrophy,
recente therapeutic advances for an old challenge. Nat Rev
Neurol.2015; 351-9.
9. Chirimoya CA, Swoboda KJ, Darras BT, Iannaccone ST, Monte
J, De Vivo DC, Norris DA, Bennet CF, Bishop KM. Results from
a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with
spinal muscular atrophy. Neurology 2016;86:890-7.
10. Ching S, Wong Y, Hui J, Wong H, Ong H. Pulmonary function and
scoliosis in children with spinal muscular atrophy types II and
III. J Paediatr Child Health. 2003; 39(9).
11. Bersanini C, Khirani S, Ramirez A, et al. Nocturnal hypoxaemia
and hypercapnia in children with neuromuscular disorders. Eur
Respir J 2012;39:1206–12. Escoliases.
12. Swoboda KJ, Prior TW, Scott CB, et al. Natural history of
denervation in SMA: relation to age, SMN2 copy number, and
function. Ann Neurol 2005;57(5):704–12.
13. Torres-Castro R; Monge G; Vera R; Puppo H; Cespedes J; Vilaro
J. Estrategias terapeuticas para aumentar la eficacia de la tos
en pacientes con enfermedades neuromusculares. Rev Med Chil
2014 Feb;142(2):238-45.
14. Bianchi C, Baiardi P. Cough peak flows: standard values
for children and adolescents. Am J Phys Med Rehabil
2008;87(6):461–7.
15. Aguerre V. Consenso de cuidados respiratorios en enfermedades
neuromusculares en ninos: resumen ejecutivo. Arch Argent
Pediatr 2014 Oct;112(5):476-7.
16. Hull J, Aniapravan R, Chan E, Chatwin M, Forton J, Gallagher
J, et al. British Thoracic Society guideline for respiratory
management of children with neuromuscular weakness.
Thorax. 2012;67(i):1–40 Society BT. Guidelines for respiratory
management of children with neuromuscular weakness.
Thorax. 2012 Julio; 67(1).
17. Martínez-Llores J, Ausín P, Roig A, Balañá A , Admetlló M,
Muñoz L, et al. Presión inspiratoria nasal: ¿una alternativa
para la evaluación de la fuerza muscular inspiratoria? Arch
Bronconeumol 2011;47:169-¬75 ¬.
18. Marques TBC, Neves J de C, Portes LA, Salge JM, Zanoteli E, Reed
UC. Air stacking: effects on pulmonary function in patients
with spinal muscular atrophy and in patients with congenital
muscular dystrophy. Jornal Brasileiro de Pneumologia.
2014;40(5):528-534.
19. Chatwin M. How to use a mechanical insufflator-exsufflator
‘cough assist machine’. Breathe. 2008;4:320–9.
20. Nygren-Bonnier M, Markstrom A, Lindholm P, Mattsson E,
Klefbeck B. Glossopharyngeal pistoning for lung insufflation
in children with spinal muscular atrophy type II. Acta Paediatr
2009; 98: 1324–1328.
21. Chatwin M, Bush A, Simonds AK. Outcome of goal-directed
non-invasive ventilation and mechanical insufflation/
exsufflation in spinal muscular atrophy type I. Arch Dis Child
2011;96(5):426-32.
22. Initiating Noninvasive Management of Respiratory Insufficiency
in Neuromuscular Disease Joshua O. Benditt,MD. Pediatrics
2009;123:S236–S238.
23. Prado F, Salinas P, Pizarro G, Campos C, Zenteno D. Asistencia
ventilatoria no invasiva en pediatría. Rev Chil Pediatr 2008;
79 (6): 580-592.
24. Treatment of nocturnal sleep disturbance can result in
improved quality of life, reduced daytime hypercarbia, and
increased survival rates.3. Simonds AK. Home ventilation. Eur
Respir J Suppl. 2003;47: 38s–46s.
25. Petrone A1, Pavone M, Testa MB, Petreschi F, Bertini E,
Cutrera R. Noninvasive ventilation in children with spinal
muscular atrophy types 1 and 2. Am J Phys Med Rehabil. 2007
Mar;86(3):216-21.
26. Zerres K, Rudnik-Schoneborn S. Natural history in proximal
spinal muscular atrophy. Arch Neurol. 1995;52(5):518-23.
27. Bach JR. Prevention of precuts excavated for children with
spinal muscular atrophy type I. Am J Phys Med Rehabil
2003;82:815-819.
28. Tassie B, Isaacs D, Kilham H, Kerridge I. Management of children
with spinal muscular atrophy type 1 in Australia. J. Paediatr.
Child Health 2013; 49: 815–19.
29. Bush A, Fraser J, Jardine E, Paton J, Simonds A, Wallis C.
Respiratory management of the infant with type 1 spinal
muscular atrophy. Arch Dis Child 2005;90(7):709–11.
30. Bach JR. The use of mechanical ventilation is appropriate in
children with genetically proven spinal muscular atrophy type
1: the motion for. Pediatric Respiratory Reviews 2008;9,45-
50.
31. Ryan M. The use of invasive ventilation is appropriate in
children with genetically proven spinal muscular atrophy type
1: the motion against. Paaediatric Respiratory Reviews 2008
[ATROFIA MUSCULAR ESPINAL: MANEJO RESPIRATORIO EN LA PERSPECTIVA DE LOS RECIENTES AVANCES... - Dra. María Angélica Palomino y col.]